Practice
Featured experience
Trial victory for ExxonMobil in tax litigation
We secured a decision affirming ExxonMobil’s entitlement to significant interest expense deductions arising out of a multi…
Non-custodial sentence for former Fiat Chrysler engineer in emissions case
We represented the defendant in a criminal prosecution and secured a time-served sentence
Trial victory for Comcast in patent litigation brought by WhereverTV
We secured a ruling of no infringement on behalf of Comcast
Rare dismissal of criminal antitrust charge against chicken supply executive
We secured the dismissal of price-fixing and bid-rigging charges brought by the DOJ Antitrust Division against Jason McGuire
Royal Bank of Scotland resolution of U.S. foreign exchange investigations
Davis Polk advised The Royal Bank of Scotland plc (“RBS”) on investigations conducted by the U.S. Department of Justice (…
Davis Polk Advises Moinian Limited on $361 Million Bond Issuance on the Tel Aviv Stock Exchange
Davis Polk acted as U.S. adviser to Moinian Limited on its NIS 1.4 billion bond issuance on the Tel Aviv Stock Exchange (…
Connacher CBCA Plan of Arrangement
Davis Polk advised the administrative agent under Connacher Oil and Gas Limited’s first-lien credit agreement, in connection…
Davis Polk Advises Micrel on Its Sale to Microchip
Davis Polk is advising Micrel, Incorporated in connection with its sale to Microchip Technology Incorporated for a total…
Davis Polk Wins Motion to Dismiss in Prosensa Securities Litigation
On May 5, 2015, Davis Polk achieved a total victory in a securities litigation filed against its clients Prosensa Holding N…
Davis Polk Advises Mavenir on Its Acquisition by Mitel
Davis Polk is advising Mavenir Systems, Inc. in connection with the acquisition of all of its outstanding shares of common…
McGraw Hill and Standard & Poor’s landmark settlements with DOJ, states and SEC
Davis Polk advised McGraw Hill Financial, Inc. (“McGraw Hill”) and Standard & Poor’s Financial Services LLC (“Standard …
Davis Polk Obtains Dismissal for Orexigen Directors in a Stock Compensation Derivative Litigation
Davis Polk represents several current and former directors of Orexigen Therapeutics (the “Company”) in connection with…
Davis Polk Achieves Major Victory for Morgan Stanley in Section 10(b) Class Action Arising from Subprime Trading Losses
Davis Polk achieved a major victory on behalf of Morgan Stanley and certain of its officers and directors in a Section 10(b)…
Davis Polk Wins Patent Infringement Case on Behalf of Comcast
Davis Polk represents various subsidiaries of Comcast Corp. in four patent infringement lawsuits against Sprint…